Disruption of the androgen–AR axis, either through surgical castration or with abiraterone, significantly enhanced T cell anti-tumor activity in male mice and improved the efficacy of anti-PD-1 immunotherapy in bladder cancer, colorectal cancer, and melanoma [130,132,137]. This evidence concerns the gene AR and colorectal cancer.